Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | 146,85 € | 236,30 € | 60,91 % |
| Neurocrine Bioscience | 33 | 0 | 4 | 0 | 125,45 € | 140,87 € | 12,29 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 6 | 0 | 35,60 € | 85,51 € | 140,20 % |
| United Therapeutics | 22 | 0 | 4 | 0 | 290,90 € | 288,66 € | -0,77 % |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | 7,54 € | 26,24 € | 248,14 % |
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,09 € | 26,01 € | 29,45 % |
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 4 | 0 | 22,21 € | 54,74 € | 146,48 % |
| Halozyme Therapeutics Inc. | 18 | 0 | 4 | 0 | 47,67 € | 49,59 € | 4,02 % |
| PTC Therapeutics Inc. | 16 | 9 | 2 | 4 | 32,40 € | 41,51 € | 28,13 % |
| Xencor Inc. | 14 | 1 | 4 | 0 | 17,80 € | 31,70 € | 78,07 % |
| Charles River Labs Intl | 11 | 0 | 1 | 0 | 194,10 € | 249,59 € | 28,59 % |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | 373,40 € | 419,64 € | 12,38 % |
| Agios Pharmaceuticals Inc. | 8 | 0 | 2 | 0 | 39,80 € | 43,87 € | 10,22 % |
| Amicus Therapeutics Inc. | 7 | 0 | 1 | 0 | 9,15 € | 17,64 € | 92,76 % |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,00 € | 3,70 € | 269,63 % |
| Emergent Biosolutions Inc. | 3 | 3 | 1 | 0 | 6,15 € | 7,46 € | 21,37 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 52,75 € | 55,00 € | 4,27 % |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | 97,98 € | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | 18,06 € | - | - |